Anhui Huangshan Capsule Co Ltd - Asset Resilience Ratio

Latest as of December 2022: 4.78%

Anhui Huangshan Capsule Co Ltd (002817) has an Asset Resilience Ratio of 4.78% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Anhui Huangshan Capsule Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥49.58 Million

≈ $7.25 Million USD Cash + Short-term Investments

Total Assets

CN¥1.04 Billion

≈ $151.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2022)

This chart shows how Anhui Huangshan Capsule Co Ltd's Asset Resilience Ratio has changed over time. See Anhui Huangshan Capsule Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Anhui Huangshan Capsule Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Anhui Huangshan Capsule Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥49.58 Million	4.78%
Total Liquid Assets	CN¥49.58 Million	4.78%

Asset Resilience Insights

Limited Liquidity: Anhui Huangshan Capsule Co Ltd maintains only 4.78% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Anhui Huangshan Capsule Co Ltd Industry Peers by Asset Resilience Ratio

Compare Anhui Huangshan Capsule Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Cipla Limited NSE:CIPLA	Drug Manufacturers - Specialty & Generic	20.75%
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.92%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	11.00%

Annual Asset Resilience Ratio for Anhui Huangshan Capsule Co Ltd (2016–2022)

The table below shows the annual Asset Resilience Ratio data for Anhui Huangshan Capsule Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	4.78%	CN¥49.58 Million ≈ $7.25 Million	CN¥1.04 Billion ≈ $151.85 Million	-1.40pp
2021-12-31	6.18%	CN¥65.14 Million ≈ $9.53 Million	CN¥1.05 Billion ≈ $154.21 Million	-4.71pp
2020-12-31	10.89%	CN¥99.77 Million ≈ $14.60 Million	CN¥915.81 Million ≈ $134.01 Million	+1.09pp
2019-12-31	9.80%	CN¥81.54 Million ≈ $11.93 Million	CN¥831.80 Million ≈ $121.72 Million	-2.38pp
2017-12-31	12.18%	CN¥90.00 Million ≈ $13.17 Million	CN¥738.73 Million ≈ $108.10 Million	-10.70pp
2016-12-31	22.88%	CN¥160.00 Million ≈ $23.41 Million	CN¥699.36 Million ≈ $102.34 Million	--

pp = percentage points

About Anhui Huangshan Capsule Co Ltd

SHE:002817 China Drug Manufacturers - Specialty & Generic

Market Cap

$316.88 Million

CN¥2.17 Billion CNY

Market Cap Rank

#14802 Global

#4522 in China

Share Price

CN¥7.24

Change (1 day)

-2.16%

52-Week Range

CN¥6.87 - CN¥8.54

All Time High

CN¥62.96